We often remind people about getting regular mammograms, but self-checks are also important — what are some specific early signs of breast cancer people should look out for?

This marks the first and only antibody drug conjugate in India with a tumour-agnostic indication, representing a significant ...

Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...

During a live event, Claudine Isaacs, MD, discussed using elacestrant for hormone receptor–positive, HER2-low metastatic ...

Daiichi Sankyo submits sNDA to Japan’s MHLW for Enhertu plus pertuzumab to treat patients with HER2 positive unresectable or recurrent breast cancer: Tokyo Wednesday, October 8, ...

Bangalore: AstraZeneca Pharma India Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO ...

Findings from DESTINY-Breast11 showed T-DXd followed by THP demonstrated a statistically significant and clinically meaningful improvement in pCR rate vs ddAC-THP.

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...

Our Bureau, Bengaluru Monday, October 6, 2025, 17:30 Hrs [IST] ...

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily ...

October is Breast Cancer Awareness Month, a time when breast cancer screenings are promoted, breast cancer survivors are honored, the public is educated about risk factors for developing breast cancer ...

Company will share data demonstrating CD47 overexpression as key predictive biomarker for response with the Company’s lead ...